Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates

This publication has 30 references indexed in Scilit:

• Nitric Oxide Versus Prostaglandin E1 for Reduction of Pulmonary Hypertension in Heart Transplant Candidates
  The Journal of Heart and Lung Transplantation, 2005
• In the long term heart transplantation provides additional benefit in transplant candidates with uptitrated ACE-inhibitor- and β-blocker-therapy
  The Journal of Heart and Lung Transplantation, 2005
• Urapidil reduces elevated pulmonary vascular resistance in patients before heart transplantation
  The Journal of Heart and Lung Transplantation, 2002
• Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation
  The Journal of Heart and Lung Transplantation, 2001
• Pretransplant risk factors of early mortality after orthotopic heart transplantation
  Transplantation Proceedings, 1999
• Reevaluating the significance of pulmonary hypertension before cardiac transplantation: Determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality
  The Journal of Thoracic and Cardiovascular Surgery, 1997
• Effect of Bolus Milrinone on Hemodynamic Variables and Pulmonary Vascular Resistance in Patients With Severe Left Ventricular Dysfunction: A Rapid Test for Reversibility of Pulmonary Hypertension
  Journal of the American College of Cardiology, 1996
• Heart transplant candidates at high risk can be identified at the time of initial evaluation
  Transplant International, 1996
• Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: The Pittsburgh experience
  American Heart Journal, 1993
• Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: Testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group
  Journal of the American College of Cardiology, 1992